مباشر
Endpoints NewsAfter 'redesign,' WuXi Biologics sets new timeline for Massachusetts factory completionBioPharma DiveRegenxbio to resubmit gene therapy as FDA backtracks on another drug rejectionEndpoints NewsMapLight to discuss autism drug's future with FDA after Phase 2 missBioPharma DiveSanofi swaps R&D leaders; Merck’s Prometheus deal pays dividendsEndpoints NewsLilly allies with BioArctic; Antengene and Insilico sign dealsFierceBiotechIn another reversal for rare disease field, FDA to reconsider Regenxbio gene therapyBioWorldBiggest gainers and losers for June 15-19, 2026BioWorldHoliday noticeEndpoints NewsMerck's IBD drug from $10.8B Prometheus deal claims its first Phase 3 winFierceBiotechMerck’s anti-TL1A antibody from Prometheus buyout passes ph. 3 test in ulcerative colitisPharmaVoicePfizer CFO departs for consumer goods sectorFierceBiotechSanofi, Pangaea ink AI partnership deal to detect underdiagnosed genetic disease

الأرشيف

الأحدث الأقدم
الإجمالي 13665
صفحة 165 / 760
بحث --